Journal
VIRCHOWS ARCHIV
Volume 480, Issue 1, Pages 95-107Publisher
SPRINGER
DOI: 10.1007/s00428-021-03128-z
Keywords
Breast cancer; Lymph nodes; Neoadjuvant treatment; Questionnaire; Sentinel lymph nodes
Categories
Ask authors/readers for more resources
This review discusses the background and trends of SLNB, as well as European national recommendations and divergent daily practices in pathology departments. It also highlights the challenges in classifying residual nodal involvement into TNM categories in the post-neoadjuvant setting and summarizes the neoadjuvant therapy-related aspects of SLNB.
Sentinel lymph node biopsy (SLNB) has become the preferred method of surgical pathological nodal staging of early breast cancer by the end of the nineties. As the most likely sites of metastasis, the SLNs allow a more precise staging, and indeed gross sectioning, step sectioning, immunohistochemistry, and molecular staging methods have been used to disclose metastatic involvement of these lymph nodes. This review summarizes the backgrounds of SLNB, trends in related surgery and pathology. It also gives an insight into European National recommendations related to SLN and divergent daily practices in European pathology departments, on the basis of replies to questionnaires from 84 pathologists from 38 European countries. The questionnaires revealed the post-neoadjuvant setting as an area where a significant minority of pathologists report less confidence in classifying residual nodal involvement into TNM categories. The review also summarizes the neoadjuvant therapy-related aspects of SLNB.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available